Published in Drug Law Weekly, April 17th, 2007
As per the recently signed multi-year agreement, Ranbaxy will be able to progress and further profile this drug candidate through pre-clinical studies needed to support an Investigational New Drug (IND) application. Ranbaxy will also be responsible for conducting Phase I and Phase II...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly